Kalbitor and Quincke's disease - a phase IV clinical study of FDA data
Quincke's disease is found among people who take Kalbitor, especially for people who are female, 40-49 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Kalbitor and have Quincke's disease. It is created by eHealthMe based on reports of 1,872 people who have side effects when taking Kalbitor from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
1,872 people reported to have side effects when taking Kalbitor.
Among them, 787 people (42.04%) have Quincke's disease.
What is Kalbitor?
Kalbitor has active ingredients of ecallantide. eHealthMe is studying from 1,873 Kalbitor users for its effectiveness, alternative drugs and more.
What is Quincke's disease?
Quincke's disease (a form of localized swelling of the deeper layers of the skin and fatty tissues beneath the skin) is found to be associated with 962 drugs and 477 conditions by eHealthMe.
Number of Kalbitor and Quincke's disease reports submitted per year:
Time on Kalbitor when people have Quincke's disease *:
Gender of people who have Quincke's disease when taking Kalbitor*:
Age of people who have Quincke's disease when taking Kalbitor *:
Common drugs people take besides Kalbitor *:
Common side effects people have besides Quincke's disease *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Kalbitor and have Quincke's disease?Check whether Quincke's disease is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Quincke's disease and when was it recovered:
Expand to all the drugs that have ingredients of ecallantide:
Alternative drugs to, pros and cons of Kalbitor:
- Kalbitor (1,873 reports)
Common Kalbitor side effects:
- Hereditary angioedema (recurrent episodes of severe swelling): 787 reports
- Drug ineffective: 143 reports
Browse all side effects of Kalbitor:a b c d e f g h i j k l m n o p q r s t u v w x y z
Quincke's disease treatments and more:
- Quincke's disease (16,202 reports)
COVID vaccines that are related to Quincke's disease:
- Quincke's disease in Moderna COVID Vaccine
- Quincke's disease in Pfizer BioNTech Covid Vaccine
- Quincke's disease in Johnson and Johnson Covid Vaccine
Common drugs associated with Quincke's disease:
- Firazyr: 1,985 reports
- Kalbitor: 787 reports
- Heparin: 440 reports
- Hydramine: 413 reports
- Diphen: 413 reports
- Epipen: 379 reports
- Zofran: 293 reports
- Zyrtec: 273 reports
- Benadryl: 260 reports
- Vitamin d: 217 reports
All the drugs that are associated with Quincke's disease:
- Quincke's disease (962 drugs)
Common conditions associated with Quincke's disease:
- Hereditary angioedema: 1,067 reports
- Preventive health care: 680 reports
All the conditions that are associated with Quincke's disease:
- Quincke's disease (477 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on ecallantide (the active ingredients of Kalbitor) and Kalbitor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Lasix and Application Site Vesicles - 7 seconds ago
- Lopurin and Maternal Condition Affecting Foetus - 15 seconds ago
- Pioglitazone and Anorexia - 20 seconds ago
- Horizant and Thiamine drug interaction - 22 seconds ago
- Atenolol and Stools - Watery - 24 seconds ago
- Atenolol and Diarrhea - 24 seconds ago
- Cipro and Skin Striae - 24 seconds ago
- Glucophage Xr and Weight Loss - 26 seconds ago
- Alpha - Lipoic Acid vs. Lipitor - 41 seconds ago
- Ziac and Completed Suicide - 41 seconds ago